A notable instance involves a patient mutation that produced a quasi-dysferlin, which, restored membrane repair in dysferlin-deficient mice, but did not mitigate the distinctive dysferlinopathy-related muscle pathologies [151,152]. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.